Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.70
-0.09 (-1.55%)
At close: May 29, 2026, 4:00 PM EDT
5.96
+0.26 (4.56%)
After-hours: May 29, 2026, 7:04 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $35.27 million as of May 29, 2026. Its market cap has increased by 3.75% in one year.
Market Cap
35.27M
Enterprise Value
-15.28M
1-Year Change
3.75%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $35.27M, a decrease of -93.63%. That is a compound annual growth rate of -38.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 35.27M | -38.50% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 38.04M |
| INmune Bio | 37.49M |
| GridAI Technologies | 37.32M |
| ABVC BioPharma | 35.63M |
| Lite Strategy | 34.37M |
| Daré Bioscience | 33.40M |
| Evaxion | 33.36M |
| Tevogen Bio Holdings | 32.54M |